Trusts and foundations
Gifts from private trusts and foundations have allowed us to pursue novel questions and groundbreaking research into a range of diseases that would not have been funded via traditional granting bodies. With their support, the potential for the treatment, prevention and cure of these diseases is much more attainable.
Through their private ancillary fund, Dr Thomas Girgensohn and Mrs Ingeborg Girgensohn currently support an innovative cancer research project which aims to uncover the molecular mechanisms cancer cells use to ‘outsmart’ targeted anti-cancer therapies and develop drug resistance.
In addition, they have generously committed to the ongoing sustainability of our work, leaving a legacy to Garvan as Partners for the Future. As they acknowledge: beating cancer will be an incremental process that may continue for generations to come. Their generosity however will help ensure researchers can continue to make discoveries that will outlive us all.